Guo Rui, Weingärtner Sebastian, Šiurytė Paulina, T Stoeck Christian, Füetterer Maximilian, E Campbell-Washburn Adrienne, Suinesiaputra Avan, Jerosch-Herold Michael, Nezafat Reza
Department of Medicine (Cardiovascular Division), Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts, USA.
Department of Imaging Physics, Magnetic Resonance Systems Lab, Delft University of Technology, Delft, The Netherlands.
J Magn Reson Imaging. 2022 Apr;55(4):1043-1059. doi: 10.1002/jmri.27848. Epub 2021 Jul 31.
Cardiovascular disease is the leading cause of death and a significant contributor of health care costs. Noninvasive imaging plays an essential role in the management of patients with cardiovascular disease. Cardiac magnetic resonance (MR) can noninvasively assess heart and vascular abnormalities, including biventricular structure/function, blood hemodynamics, myocardial tissue composition, microstructure, perfusion, metabolism, coronary microvascular function, and aortic distensibility/stiffness. Its ability to characterize myocardial tissue composition is unique among alternative imaging modalities in cardiovascular disease. Significant growth in cardiac MR utilization, particularly in Europe in the last decade, has laid the necessary clinical groundwork to position cardiac MR as an important imaging modality in the workup of patients with cardiovascular disease. Although lack of availability, limited training, physician hesitation, and reimbursement issues have hampered widespread clinical adoption of cardiac MR in the United States, growing clinical evidence will ultimately overcome these challenges. Advances in cardiac MR techniques, particularly faster image acquisition, quantitative myocardial tissue characterization, and image analysis have been critical to its growth. In this review article, we discuss recent advances in established and emerging cardiac MR techniques that are expected to strengthen its capability in managing patients with cardiovascular disease. LEVEL OF EVIDENCE: 5 TECHNICAL EFFICACY: Stage 1.
心血管疾病是主要的死亡原因,也是医疗保健成本的重要贡献因素。非侵入性成像在心血管疾病患者的管理中起着至关重要的作用。心脏磁共振成像(MR)可以非侵入性地评估心脏和血管异常,包括双心室结构/功能、血液动力学、心肌组织成分、微观结构、灌注、代谢、冠状动脉微血管功能以及主动脉扩张性/僵硬度。在心血管疾病的其他成像方式中,其表征心肌组织成分的能力是独一无二的。心脏MR应用的显著增长,尤其是在过去十年的欧洲,为将心脏MR定位为心血管疾病患者检查中的重要成像方式奠定了必要的临床基础。尽管可用性不足、培训有限、医生犹豫以及报销问题阻碍了心脏MR在美国的广泛临床应用,但越来越多的临床证据最终将克服这些挑战。心脏MR技术的进步,特别是更快的图像采集、定量心肌组织表征和图像分析,对其发展至关重要。在这篇综述文章中,我们讨论了既定和新兴心脏MR技术的最新进展,这些进展有望增强其在管理心血管疾病患者方面的能力。证据水平:5 技术疗效:1期